Powerpack

Unlock full stockrow access for only $7.9/month and boost yourself as an investor.

Watchlist

Keep track of companies that you follow and research.

10 Years of Data

Full access to our data with predictions and indicators that we calculate daily.

Screener

Full access to our screener with tons of custom values and customizable email notifications.

XLS Exports

Excel export of financials and screeners you define and save.

John Wiley & Sons, Inc. WLY

Growth Flags show if company had growth for consecutive years

Analyst’s Commentary of John Wiley & Sons, Inc. (WLY) Performance

John Wiley & Sons, Inc. (WLY), a venerable player in academic publishing and educational services, presents a mixed picture for conservative investors. The company has endured significant turbulence over the past decade, marked by revenue peaks followed by sharp declines, episodic losses, and structural shifts in its industry. While analyst forecasts point to a potential rebound in earnings, the persistent downward pressure on revenue—coupled with a weakening balance sheet and recent insider selling—raises substantial downside risks. Stock performance has closely mirrored these fundamentals, trading at depressed levels relative to historical highs, now approximately 104% below consensus analyst price targets. This report examines key trends, risks, and projections through a risk-averse lens, prioritizing steady cash flows and balance sheet resilience over speculative growth.

Revenue Trends and Operational Efficiency

Revenue growth was a bright spot from 2016 to 2022, expanding from $1.73 billion to $2.08 billion—a cumulative 20.6% increase driven by acquisitions and digital content expansion. Revenue per share rose steadily from $29.78 to $37.36, underscoring effective share count management amid growth. However, this trajectory reversed sharply post-2022, with 2024 revenue falling to $1.87 billion (down 7.3% from $2.02 billion in 2023) and projected to dip further to $1.68 billion in 2025 (an 10.4% decline). Analyst predictions for 2026-2028 show modest stabilization around $1.66-$1.70 billion, implying flat to low-single-digit growth at best.

This decline correlates strongly with workforce reductions, as employees ballooned to 9,500 in 2022 before plummeting to a forecasted 5,200 by 2025—a 45% cut. Revenue per employee, a key productivity metric, reflects this: it bottomed at $219,000 in 2022 amid expansion but rebounded to $323,000 projected for 2025, signaling cost discipline. Yet, for risk-averse investors, this efficiency gain comes with caveats—over-reliance on headcount cuts could hinder innovation in a sector disrupted by open-access publishing and AI-driven content tools.

Gross margins provide some reassurance, dipping to 65.7% in 2023 before recovering to 69.1% in 2024 and a robust 74.3% forecast for 2025. Improving margins are crucial as they buffer against revenue softness, but historical volatility (from 73.0% in 2016) highlights vulnerability to input costs and digital transition expenses.

Profitability Volatility and Earnings Quality

Profitability has been erratic, with EBT margin peaking at 11.9% in 2018 before plunging to -10.0% in 2024—a stark reminder of operational leverage risks. Net income followed suit: $192 million in 2018 gave way to a $74 million loss in 2020 (COVID-driven enrollment drops) and a steeper $200 million loss in 2024 (down 1,262% from 2023’s $17 million). Forecasts brighten, with $84 million expected in 2025 (a 142% turnaround) and $164-$190 million in 2026-2027, potentially lifting earnings per share to $3.08-$3.63 from a dismal -$3.65 in 2024.

Return on equity (ROE), a core gauge of shareholder value creation, swung from 17.5% in 2018 to -22.5% in 2024, while ROIC hovered below 10% recently (projected 9.4% in 2025). These metrics underscore downside risks: high fixed costs in publishing amplify revenue misses. Free cash flow per share, vital for dividend sustainability and debt reduction, declined from $4.59 in 2021 to $2.19 projected for 2025 (down 52% from 2022 peak), with total FCF at $118 million in 2025 versus $227 million in 2022 (-48%). Positive FCF remains a steady performer, but shrinking scale erodes its margin of safety.

Balance Sheet Strength and Leverage Concerns

Wiley’s balance sheet shows resilience but flashing warning signs. Shareholders’ equity peaked at $1.19 billion in 2018 before eroding to $752 million in 2025 (-37% from 2022’s $1.14 billion), driven by losses and share repurchases. Book value per share mirrors this, falling from $20.49 in 2022 to $13.92 projected (-32%). More troubling is leverage: total debt steady at $750-$800 million, with net debt climbing to $714 million in 2025 (up 3% from 2024). This yields a net debt-to-equity ratio implicitly over 90%, pressuring interest coverage amid thin margins.

Working capital remains negative (around -$380 million to -$420 million), typical for publishing’s advance-heavy model but amplifying liquidity risks during downturns. Depreciation, at $148 million forecasted for 2025 (down 48% from 2023’s $314 million), suggests asset write-downs or slower capex, with capex/share stabilizing near -$1.56. For balance-sheet-focused investors, these trends prioritize caution: while EV/sales at ~1.8x (2025) is reasonable, EV/FCF nearing 25x signals overvaluation if cash flows disappoint.

Stock Price Evolution and Valuation Metrics

The stock’s price range tells a cautionary tale of fundamental linkage. From 2016 highs near 104% above recent levels to 2020 lows during pandemic woes, shares broadly tracked revenue and earnings cycles—rallying 50%+ from 2020 lows to 2022 peaks amid recovery, then shedding value as declines set in. By 2025, highs were still ~60% above the most recent close, reflecting market skepticism.

Valuation multiples reflect this volatility: P/E ballooned to 123x in 2023 (low earnings) and remains projected at 28x for 2025, versus historical teens—risky if earnings falter. P/S at 1.4x (2025) and P/B at 3.1x suggest modest appeal, but compared to steady peers, Wiley trades at a discount for good reason. Consensus targets imply ~104% upside from recent levels, but with uniform high/mean/low alignment, this unanimity warrants scrutiny amid downside scenarios.

Insider Activity and Market Signals

Insider transactions offer no comfort: zero buys across 2025-2026 periods, contrasted by sells totaling over $770,000 in value. Notable activity included a director’s 3,390-share sale in March 2025, an SVP’s 3,000 shares in June, and clustered EVP/SVP sales in July (11,000+ shares combined). While routine (e.g., option exercises), the absence of buys amid a beaten-down stock signals limited internal confidence, correlating with post-restructuring uncertainty.

Key Events Shaping the Trajectory

Major events amplify these risks. The 2020 COVID shock hammered higher education spending, triggering Wiley’s first major loss. More recently, 2023-2024 saw aggressive restructuring: divestitures of non-core assets, a 30%+ workforce reduction, and June 2024’s announcement to separate its Research Publishing business from Learning/University Services. This spin-off aims to unlock value but introduces execution risks—tax implications, integration hiccups, and market reception remain unknowns. Industry-wide, open-access mandates and generative AI threaten traditional journal revenues, which comprise ~60% of Wiley’s mix, pressuring long-term moats.

Future Outlook and Risk-Averse Recommendations

Analyst predictions sketch a stabilizing path: revenue flatlining around $1.66 billion through 2028, net income climbing to $190 million by 2027 (up 126% from 2025), and EPS at $3.63—potentially normalizing P/E to single digits if realized. Cash flow per share could recover modestly, supporting debt paydown or dividends (historically ~3% yield). Revenue/employee productivity gains and gross margin expansion to 74% bolster this, positioning Wiley as a turnaround candidate.

Yet, as a risk-averse pragmatist, I emphasize tail risks: persistent revenue erosion (already -3% CAGR since 2022), leverage constraining flexibility, and FCF vulnerability to capex spikes or spin-off costs. ROE rebound to 11.3% (2025) is promising but lags steady performers like peers in diversified media. Stock upside to targets assumes flawless execution; a 20% revenue miss could halve projected earnings.

In summary, Wiley offers asymmetric potential but demands caution—monitor spin-off progress and Q1 2026 results closely. For conservative portfolios, await sub-10x P/E confirmation and insider buy signals before meaningful allocation. Downside protection via balance sheet hedges remains paramount.

(Word count: 1,128)